VINSE REU
-
Spotlight Publication: “Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody–STING agonist conjugates” published in Nature Biomedical Engineering
a, Scheme depicting the concept of an albumin-hitchhiking nanobody–STING agonist conjugate for cancer immunotherapy. Anti-albumin nanobodies conjugated to STING agonists bind to circulating albumin in situ, resulting in improved pharmacokinetics and increased biodistribution to tumour sites that stimulates antitumour innate and adaptive immune responses. b, Computational model of the anti-albumin… Read MoreJan. 20, 2026